Replies to post #458050 on Anavex Life Sciences Corp (AVXL)

[Jonjones325]

I think they know that and it’s something they can’t do on the fly if they want to succeed.

All the expertise will be brought in through a partnership. Hopefully very soon. That’s most likely the reason we haven’t seen any new hires in this area. Like you said there is a lot of pre commercial activity that needs to be done in order to ramp up properly.

Last years ASM was on May 23rd so we’re not late yet. For those who are speculating that something is in the works.

[plexrec]

Dr Jan--" Missling uses his scientific gut feeling"--good post sad to say--many good points made by you---also I have similar opinion !!!!

[sage4]

I hate to say like "oh you're a FUD" because it hurts my pride, haha. But oh man oh man you are just too much.
All 4 negative messages(rightly mixed with sum positive, lol) On the Day 1??? You really suck in acting. lol

[Steady_T]

No real reason to start that full court process yet. Anavex has been doing some of that already by presenting at the various health conferences and investor conferences. Those areas target the KOLs directly.

There is a significant amount of time before the first approval can arrive. Which means bringing that sort of skill set on board too early is a waste of resources.
As another poster commented, those skills may come with a partnership rather than needing to be in house.

But hey, it's something to bad mouth the company over so let's not forget that.

[crescentmotor]

Your post contained a lot of good information about the criticality of marketing and sales experience necessary for successfully marketing a drug. Nonetheless, focus is putting the cart before the horse. KOLs will not get the Blarcamesine approved for the treatment of Alzheimer's. Regulatory approval is the end result of trials that have convincing data that meets established standards for efficacy that exceed any downsides of adverse events. That approval process lies squarely on the shoulders of Missling and AVXL. To date, some limited progress toward regulatory approval has occurred but nothing significant such as the filing of applications for approval. In that regard, the ball remains under center and play has not commenced. Once the ball is moved, partners, key opinion leaders, drug advocates, patient groups, etc. can be brought into the game as additional players.

[XenaLives]

oops...

There are no competitors.
"major countries" are already paying out big bucks for useless crap,


Your post is fictional dreck.

[Investor2014]

Ma probably paved the way to the groundbreaking Partex partnerships of which will come very little of any benefit unless and until Anavex get a drug to market. To date no regulator has received a marketing authorisation application to look at in its full glory of endless pages upon pages.